| Announcements, Featured

1 year data presentation from FIREFISH clinical trial of Risdiplam in neonates with SMA I, Roche Pharmaceuticals

Roche Pharmaceuticals announced encouranging news yesterday 28/4:

  • 29% of infants participated sit without support
  • 31.7% are able to roll to the side
  • 4.9% are able to stand with support

For further information, click here to read the official press release:


(retreived from Scientific Announcement https://mdahellas.gr/oi-neyromyikes-pathiseis/episthmonikes-dhmosieuseis/)


Comments are closed.